MEI Pharma, Inc.
MEIP
$2.04
$0.042.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.68M | -8.01M | -18.41M | -9.13M | -11.06M |
| Total Depreciation and Amortization | 0.00 | 368.00K | 125.00K | 86.00K | 85.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -598.00K | 88.00K | 12.63M | 1.05M | 1.23M |
| Change in Net Operating Assets | -391.00K | -3.90M | -12.34M | 5.06M | -1.31M |
| Cash from Operations | -3.67M | -11.45M | -18.00M | -2.93M | -11.06M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -7.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 10.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.45M | 14.69M | 19.54M | 122.00K | 24.52M |
| Cash from Investing | 20.45M | 14.70M | 19.54M | 122.00K | 24.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -208.00K | 0.00 | -11.66M |
| Cash from Financing | -- | -- | -208.00K | 0.00 | -11.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.79M | 3.25M | 1.34M | -2.81M | 1.80M |